ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Invasive Cancer of the Cervix: 2023 Update

Authors

Atul B. Shinagare, Brigham & Women's Hospital Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: ashinagare@bwh.harvard.edu.
Kristine S. Burk, Research Author, Brigham & Women's Hospital, Boston, Massachusetts.
Aoife Kilcoyne, Panel Chair, Massachusetts General Hospital, Boston, Massachusetts.
Esma A. Akin, The George Washington University Medical Center, Washington, District of Columbia; Commission on Nuclear Medicine and Molecular Imaging.
Linus Chuang, University of Vermont Larner College of Medicine Danbury Hospital, Burlington, Vermont; Gynecologic oncology expert.
Nicole M. Hindman, New York University School of Medicine, New York, New York.
Chenchan Huang, New York University Langone Medical Center, New York, New York.
Gaiane M. Rauch, The University of Texas MD Anderson Cancer Center, Houston, Texas.
William Small, Loyola University Chicago, Stritch School of Medicine, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Maywood, Illinois; Commission on Radiation Oncology.
Erica B. Stein, University of Michigan Medical Center, Ann Arbor, Michigan.
Aradhana M. Venkatesan, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Stella K. Kang, Specialty Chair, New York University Medical Center, New York, New York.

Document Type

Journal Article

Publication Date

6-1-2024

Journal

Journal of the American College of Radiology : JACR

Volume

21

Issue

6S

DOI

10.1016/j.jacr.2024.02.026

Keywords

AUC; Appropriateness Criteria; appropriate use criteria; carcinoma of the cervix; cervical cancer; pretreatment evaluation; response assessment; staging

Abstract

Cervical cancer is a common gynecological malignancy worldwide. Cervical cancer is staged based on the International Federation of Gynecology and Obstetrics (FIGO) classification system, which was revised in 2018 to incorporate radiologic and pathologic data. Imaging plays an important role in pretreatment assessment including initial staging and treatment response assessment of cervical cancer. Accurate determination of tumor size, local extension, and nodal and distant metastases is important for treatment selection and for prognostication. Although local recurrence can be diagnosed by physical examination, imaging plays a critical role in detection and follow-up of local and distant recurrence and subsequent treatment selection. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.

APA Citation

Shinagare, Atul B.; Burk, Kristine S.; Kilcoyne, Aoife; Akin, Esma A.; Chuang, Linus; Hindman, Nicole M.; Huang, Chenchan; Rauch, Gaiane M.; Small, William; Stein, Erica B.; Venkatesan, Aradhana M.; and Kang, Stella K., "ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Invasive Cancer of the Cervix: 2023 Update" (2024). GW Authored Works. Paper 5183.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/5183

Department

Radiology